Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,960.00
Bid: 1,969.00
Ask: 1,971.00
Change: 35.00 (1.82%)
Spread: 2.00 (0.102%)
Open: 1,937.00
High: 1,977.00
Low: 1,931.00
Prev. Close: 1,925.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Panmure Raises RSA Insurance To Buy From Hold

Wed, 10th Aug 2016 08:35

LONDON (Alliance News) - The following shares received analyst recommendations Wednesday morning and Tuesday:
----------
FTSE 100
----------
PANMURE RAISES RSA INSURANCE TO 'BUY' ('HOLD') - TARGET 575 (470) PENCE
----------
Investec Cuts RBS To Hold From Buy, Price Target 205p From 230p
----------
BARCLAYS CUTS LEGAL & GENERAL TARGET TO 194 (197) PENCE - 'EQUAL WEIGHT'
----------
S&P GLOBAL RAISES LEGAL & GENERAL TO 'HOLD' ('SELL') - TARGET 220 PENCE
----------
RBC CAPITAL RAISES SMITHS GROUP PRICE TARGET TO 1450 (1350) PENCE - 'OUTPERFORM'
----------
PANMURE RAISES RANDGOLD RESOURCES PRICE TARGET TO 6892 (6750) PENCE - 'HOLD'
----------
TRADERS: MORGAN STANLEY RAISES ROLLS ROYCE TO 'EQUAL-WEIGHT' ('UNDERWEIGHT') - PRICE TARGET 780 (655) PENCE
----------
BARCLAYS CUTS SMITH & NEPHEW TO 'EQUAL WEIGHT' ('OVERWEIGHT') - TARGET 1240 (1230) PENCE
----------
GOLDMAN RAISES HIKMA PHARMACEUTICAL PRICE TARGET TO 2680 (2380) PENCE - 'BUY'
----------
FTSE 250
----------
LIBERUM CUTS INTERNATIONAL PERSONAL FINANCE PT TO 267 (272) PENCE - 'HOLD'
----------
LIBERUM RAISES TULLETT PREBON PRICE TARGET TO 413 (353) PENCE - 'BUY'
----------
Numis Cuts Regus To Hold From Buy, 300p Price Target Maintained
----------
JEFFERIES RAISES IBSTOCK PRICE TARGET TO 190 (170) PENCE - 'BUY'
----------
CITIGROUP RAISES JUST EAT PRICE TARGET TO 700 PENCE - 'BUY'
----------
CREDIT SUISSE RAISES ELECTROCOMPONENTS PT TO 250 (220) PENCE - 'UNDERPERFORM'
----------
EXANE RAISES SPIRAX-SARCO PRICE TARGET TO 3700 (3400) PENCE - 'UNDERPERFORM'
----------
EXANE BNP CUTS COBHAM TO 'UNDERPERFORM' ('NEUTRAL') - TARGET 140 (143) PENCE
----------
GOLDMAN RAISES AMEC PRICE TARGET TO 691.10 (690.40) PENCE - 'BUY'
----------
GOLDMAN INITIATES INMARSAT WITH 'BUY'
----------
MAIN MARKET AND AIM
----------
LIBERUM CUTS JOHNSTON PRESS PRICE TARGET TO 160 (180) PENCE - 'BUY'
----------
JEFFERIES RAISES IMAGINATION TECHNOLOGIES PRICE TARGET TO 219 (199) PENCE - 'BUY'
----------
CITIGROUP RAISES SPIRENT PRICE TARGET TO 95 (82) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS GEM DIAMONDS PRICE TARGET TO 175 (180) PENCE - 'OVERWEIGHT'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.